CompletedNot applicableNCT01810965
Impact of Bloodletting on Iron Metabolism in Type 1 Hemochromatosis
Studying Symptomatic form of HFE-related hemochromatosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Rennes University Hospital
- Principal Investigator
- Martine Ropert-Bouchet, MDRennes University Hospital
- Intervention
- First evaluation phase : no intervention / Second evaluation phase: bloodletting of 7 ml/kg (with a maximum of 500ml)(procedure)
- Enrollment
- 6 enrolled
- Eligibility
- 18 years · MALE
- Timeline
- 2013 – 2019
Study locations (1)
- CHU Pontchaillou, Rennes, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01810965 on ClinicalTrials.govOther trials for Symptomatic form of HFE-related hemochromatosis
Additional recruiting or active studies for the same condition.
See all trials for Symptomatic form of HFE-related hemochromatosis →